Effect of deletion or overexpression of the 19-kilodalton lipoprotein Rv3763 on the innate response to Mycobacterium tuberculosis

Infection and Immunity

Volumn 73, Issue 10, 2005, Pages 6831-6837

  Stewart, Graham R ^a,c   Wilkinson, Katalin A ^a,b   Newton, Sandra M ^a   Sullivan, Susan M ^a,d   Neyrolles, Olivier ^a,e   Wain, John R ^a   Patel, Janisha ^a,f   Pool, Kara Lee ^a   Young, Douglas B ^a   Wilkinson, Robert J ^a,b  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF SURREY   (United Kingdom)

^d UNIVERSITY OF MICHIGAN   (United States)

^e INSTITUT PASTEUR   (France)

^f UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12P40; INTERLEUKIN 1BETA; LIPOPROTEIN; LIPOPROTEIN RV3763; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BACILLUS; BACTERIAL GROWTH; CELL SECRETION; GENE DELETION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; INNATE IMMUNITY; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NORMAL HUMAN; PLEIOTROPY; PRIORITY JOURNAL;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELLS, CULTURED; GENE DELETION; HLA-DR ANTIGENS; HUMANS; IMMUNITY, NATURAL; INTERLEUKIN-1; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; LIPOPROTEINS; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; PHAGOCYTES; PHAGOCYTOSIS; PROTEIN SUBUNITS; TRANS-ACTIVATION (GENETICS); TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 25444473909     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.10.6831-6837.2005     Document Type: Article

References (31)

1. Bothamley, G., H. Batra, V. Ramesh, A. Chandramuki, and J. Ivanyi. 1992. Serodiagnostic value of the 19 kilodalton antigen of Mycobacterium tuberculosis in Indian patients. Eur. J. Clin. Microbiol. Infect. Dis. 11:912-916.
2. Brennan, P. J. 2003. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinburgh) 83:91-97.
3. Brightbill, H. D., D. H. Libraty, S. R. Krutzik, R. B. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, P. J. Brennan, B. R. Bloom, P. J. Godowski, and R. L. Modlin. 1999. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285:732-736.
4. Brozna, J. P., M. Horan, J. M. Rademacher, K. M. Pabst, and M. J. Pabst. 1991. Monocyte responses to sulfatide from Mycobacterium tuberculosis: inhibition of priming for enhanced release of superoxide, associated with increased secretion of interleukin-1 and tumor necrosis factor alpha, and altered protein phosphorylation. Infect. Immun. 59:2542-2548.
5. Ciaramella, A., A. Cavone, M. B. Santucci, S. K. Garg, N. Sanarico, M. Bocchino, D. Galati, A. Martino, G. Auricchio, M. D'Orazio, G. R. Stewart, O. Neyrolles, D. B. Young, V. Colizzi, and M. Fraziano. 2004. Induction of apoptosis and release of interleukin-1β by cell wall-associated 19-kDa lipoprotein during the course of mycobacterial infection. J. Infect. Dis. 190:1167-1176.
6. Desjardin, L. E., M. D. Perkins, K. Wolski, S. Haun, L. Teixeira, Y. Chen, J. L. Johnson, J. J. Ellner, R. Dietze, J. Bates, C. M. Donald, and K. D. Eisenach. 1999. Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy. Am. J. Respir. Crit. Care Med. 160:203-210.
7. Domenech, P., M. B. Reed, C. S. Dowd, C. Manca, G. Kaplan, and C. E. Barry III. 2004. The role of MmpL8 in sulfatide biogenesis and virulence of Mycobacterium tuberculosis. J. Biol. Chem. 279:21257-21265.
8. Ernst, W. A., J. Maher, S. Cho, K. R. Niazi, D. Chatterjee, D. B. Moody, G. S. Besra, Y. Watanabe, P. E. Jensen, S. A. Porcelli, M. Kronenberg, and R. L. Modlin. 1998. Molecular interaction of CD1b with lipoglycan antigens. Immunity 8:331-340.
9. Fortune, S. M., A. Solache, A. Jaeger, P. J. Hill, J. T. Belisle, B. R. Bloom, E. J. Rubin, and J. D. Ernst. 2004. Mycobacterium tuberculosis inhibits macrophage responses to IFN-γ through myeloid differentiation factor 88-dependent and -independent mechanisms. J. Immunol. 172:6272-6280.
10. Fulton, S. A., S. M. Reba, R. K. Pai, M. Pennini, M. Torres, C. V. Harding, and W. H. Boom. 2004. Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein. Infect. Immun. 72:2101-2110.
11. Gehring, A. J., K. M. Dobos, J. T. Belisle, C. V. Harding, and W. H. Boom. 2004. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J. Immunol. 173:2660-2668.
12. Gordon, S. 2002. Pattern recognition receptors: doubling up for the innate immune response. Cell 111:927-930.
13. Lathigra, R., Y. Zhang, M. Hill, M. J. Garcia, P. S. Jackett, and J. Ivanyi. 1996. Lack of production of the 19-kDa glycolipoprotein in certain strains of Mycobacterium tuberculosis. Res. Microbiol. 147:237-249.
14. Lopez, M., L. M. Sly, Y. Luu, D. Young, H. Cooper, and N. E. Reiner. 2003. The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through Toll-like receptor-2. J. Immunol. 170:2409-2416.
15. Neyrolles, O., K. Gould, M.-P. Gares, S. Brett, R. Janssen, P. O'Gaora, J.-L. Herrmann, M.-C. Prévost, E. Perret, J. Thole, and D. Young. 2001. Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria. J. Immunol. 166:447-457.
16. Noss, E. H., R. K. Pai, T. J. Sellati, J. D. Radolf, J. Belisle, D. T. Golenbock, W. H. Boom, and C. V. Harding. 2001. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J. Immunol. 167:910-918.
17. Onwueme, K. C., J. A. Ferreras, J. Buglino, C. D. Lima, and L. E. Quadri. 2004. Mycobacterial polyketide-associated proteins are acyltransferases: proof of principle with Mycobacterium tuberculosis PapA5. Proc. Natl. Acad. Sci. USA 101:4608-4613.
18. Ortalo-Magne, A., A. Lemassu, M. A. Laneelle, F. Bardou, G. Silve, P. Gounon, G. Marchal, and M. Daffe. 1996. Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. J. Bacteriol. 178:456-461.
19. Pai, R. K., M. Convery, T. A. Hamilton, W. H. Boom, and C. V. Harding. 2003. Inhibition of IFN-γ-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. J. Immunol. 171:175-184.
20. Post, F. A., C. Manca, O. Neyrolles, B. Ryffel, D. B. Young, and G. Kaplan. 2001. The 19-kDa lipoprotein of Mycobacterium tuberculosis inhibits Mycobacterium smegmatis-induced cytokine production by human macrophages in vitro. Infect. Immun. 69:1433-1439.
21. Reed, M. B., P. Domenech, C. Manca, H. Su, A. K. Barczak, B. N. Kreiswirth, G. Kaplan, and C. E. Barry III. 2004. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431:84-87.
22. Sassetti, C. M., and E. J. Rabin. 2003. Genetic requirements for mycobacterial survival during infection, Proc. Natl. Acad. Sci. USA 100:12989-12994.
23. Schnappinger, D., S. Ehrt, M. I. Voskuil, Y. Liu, J. A. Mangan, I. M. Monahan, G. Dolganov, B. Efron, P. D. Butcher, C. Nathan, and G. K. Schoolnik. 2003. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198:693-704.
24. Spargo, B. J., L. M. Crowe, T. Ioneda, B. L. Beaman, and J. H. Crowe. 1991. Cord factor (α,α-trehalose 6,6′-dimycolate) inhibits fusion between phospholipid vesicles. Proc. Natl. Acad. Sci. USA 88:737-740.
25. Thoma-Uszynski, S., S. Stenger, O. Takeuchi, M. T. Ochoa, M. Engele, P. A. Sieling, P. F. Barnes, M. Rollinghoff, P. L. Bolcskei, M. Wagner, S. Akira, M. V. Norgard, J. T. Belisle, P. J. Godowski, B. R. Bloom, and R. L. Modlin. 2001. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291:1544-1547.
26. Tobian, A. A., N. S. Potter, L. Ramachandra, R. K. Pai, M. Convery, W. H. Boom, and C. V. Harding. 2003. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide. J. Immunol. 171:1413-1422.
27. Tsolaki, A. G., A. E. Hirsh, K. DeRiemer, J. A. Enciso, M. Z. Wong, M. Hannan, Y. O. Goguet De La Salmoniere, K. Aman, M. Kato-Maeda, and P. M. Small. 2004. Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains. Proc. Natl. Acad. Sci. USA 101:4865-4870.
28. Wilkinson, R. J., L. E. Desjardin, N. Islam, B. M. Gibson, R. A. Kanost, K. A. Wilkinson, D. Poelman, K. D. Eisenach, and Z. Toossi. 2001. An increase in expression of a M. tuberculosis mycolyl transferase gene (fbpB) occurs early after infection of human monocytes. Mol. Microbiol. 39:813-821. (Erratum, 53:1001, 2004.)
29. Wilkinson, R. J., P. Patel, M. Llewelyn, C. S. Hirsch, G. Pasvol, G. Snounou, R. N. Davidson, and Z. Toossi. 1999. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1β on tuberculosis. J. Exp. Med. 189:1863-1874.
30. Wilkinson, R. J., H. M. Vordermeier, K. A. Wilkinson, A. Sjölund, C. Moreno, G. Pasvol, and J. Ivanyi. 1998. Peptide specific response to M. tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy. J. Infect. Dis. 178:760-768.
31. Yeremeev, V. V., G. R. Stewart, O. Neyrolles, K. Skrabal, V. G. Avdienko, A. S. Apt, and D. B. Young. 2000. Deletion of the 19kDa antigen does not alter the protective efficacy of BCG. Tuber. Lung Dis. 80:243-247.